Passive Transfer of Patient-derived Anti-nephrin Autoantibodies Causes a Podocytopathy with Minimal Change Lesions
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Watts A, Keller K, Lerner G, Rosales I, Collins A, Sekulic M
. Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune Etiology. J Am Soc Nephrol. 2021; 33(1):238-252.
PMC: 8763186.
DOI: 10.1681/ASN.2021060794.
View
2.
Shirai Y, Miura K, Ishizuka K, Ando T, Kanda S, Hashimoto J
. A multi-institutional study found a possible role of anti-nephrin antibodies in post-transplant focal segmental glomerulosclerosis recurrence. Kidney Int. 2023; 105(3):608-617.
DOI: 10.1016/j.kint.2023.11.022.
View
3.
Seifert L, Riecken K, Zahner G, Hambach J, Hagenstein J, Dubberke G
. An antigen-specific chimeric autoantibody receptor (CAAR) NK cell strategy for the elimination of anti-PLA2R1 and anti-THSD7A antibody-secreting cells. Kidney Int. 2024; 105(4):886-889.
DOI: 10.1016/j.kint.2024.01.021.
View
4.
Hengel F, Dehde S, Lasse M, Zahner G, Seifert L, Schnarre A
. Autoantibodies Targeting Nephrin in Podocytopathies. N Engl J Med. 2024; 391(5):422-433.
DOI: 10.1056/NEJMoa2314471.
View